ArticleCancer management and research2019

lncRNA CADM1-AS1 inhibits cell-cycle progression and invasion via PTEN/AKT/GSK-3β axis in hepatocellular carcinoma.

Fan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.